| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000023644 |
| Receipt No. | R000027229 |
| Official scientific title of the study | A clinical research of postoperative adhesion in patients registered to previous clinical studies of THN-01 -multicenter, retrospective research- |
| Date of disclosure of the study information | 2016/09/01 |
| Last modified on | 2017/04/03 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | A clinical research of postoperative adhesion in patients registered to previous clinical studies of THN-01
-multicenter, retrospective research- |
|
| Title of the study (Brief title) | A clinical research of postoperative adhesion in patients registered to previous clinical studies of THN-01 | |
| Region |
|
|
| Condition | ||
| Condition | Ulcerative colitis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Out of the patients registered to previous two clinical studies of THN-01, the patients included in the full analysis set (FAS) used for efficacy analysis are selected for this study. The aims of this study are to estimate the factors which can affect postoperative adhesions, and to confirm and evaluate the possible factors affecting clinical outcomes, following to examination of disease conditions of ulcerative colitis, preoperative treatments, and other information. |
| Basic objectives2 | Others |
| Basic objectives -Others | Follow-up of the clinical study |
| Trial characteristics_1 | Others |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The possible factors affecting postoperative adhesion and clinical outcomes, such as disease conditions of ulcerative colitis and preoperative medical treatments |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who can provide written informed consent | |||
| Key exclusion criteria | - | |||
| Target sample size | 64 | |||
| Research contact person | |
| Name of lead principal investigator | Hisanori Saegusa |
| Organization | Otsuka Pharmaceutical Factory, Inc. |
| Division name | Clinical Development Department, Research and Development Center |
| Address | 5F Nikko Kanda Building, 1-1 Ogawa-machi, Kanda, Chiyoda-ku, Tokyo |
| TEL | 03-5280-2721 |
| saegusah@otsuka.jp | |
| Public contact | |
| Name of contact person | Yoshihiro Kume |
| Organization | Otsuka Pharmaceutical Factory, Inc. |
| Division name | Clinical Development Department, Research and Development Center |
| Address | 5F Nikko Kanda Building, 1-1 Ogawa-machi, Kanda, Chiyoda-ku, Tokyo |
| TEL | 03-5280-2721 |
| Homepage URL | |
| Kume.Yoshihiro@otsuka.jp | |
| Sponsor | |
| Institute | Otsuka Pharmaceutical Factory, Inc. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Otsuka Pharmaceutical Factory, Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | We evaluated the clinical condition and preoperative medical treatment of the patients registered in the clinical studies of THN-01 and evaluated for efficacy. As a result, the medical history of the specific drugs could affect postoperative adhesion and the results of clinical studies. |
| Other related information | Follow-up of the clinical study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027229 |